{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/6584dab850777b00169f2f1c?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Friday, December 22, 2023","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/1703205444989-469774b274fc4f442128de74bd82363a.jpeg?height=200","description":"<p>Federal antitrust regulators finalize new merger guidelines that will have a significant impact on healthcare dealmaking.&nbsp;An independent Iowa pharmacy files a lawsuit against UnitedHealth and OptumRx alleging high back-end fees. And, we’re seeing a rise in respiratory illnesses–and a new COVID variant–ahead of the holidays.&nbsp;That’s coming up on today’s episode of Gist Healthcare Daily.</p><p><br></p>","author_name":"Gist Healthcare Daily"}